- Home
- SPRY vs ECPG Comparison
SPRY vs ECPG Comparison
Compare SPRY & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- ECPG
- Stock Information
- Founded
- SPRY 2015
- ECPG 1998
- Country
- SPRY United States
- ECPG United States
- Employees
- SPRY 24
- ECPG N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- ECPG Finance Companies
- Sector
- SPRY Health Care
- ECPG Finance
- Exchange
- SPRY Nasdaq
- ECPG Nasdaq
- Market Cap
- SPRY 1.2B
- ECPG 1.2B
- IPO Year
- SPRY N/A
- ECPG 1999
- Fundamental
- Price
- SPRY $11.95
- ECPG $32.02
- Analyst Decision
- SPRY Strong Buy
- ECPG Strong Buy
- Analyst Count
- SPRY 5
- ECPG 3
- Target Price
- SPRY $26.80
- ECPG $62.67
- AVG Volume (30 Days)
- SPRY 1.3M
- ECPG 498.6K
- Earning Date
- SPRY 03-20-2025
- ECPG 05-07-2025
- Dividend Yield
- SPRY N/A
- ECPG N/A
- EPS Growth
- SPRY N/A
- ECPG N/A
- EPS
- SPRY N/A
- ECPG N/A
- Revenue
- SPRY $2,568,000.00
- ECPG $1,316,361,000.00
- Revenue This Year
- SPRY $61,233.33
- ECPG $21.62
- Revenue Next Year
- SPRY $585.54
- ECPG $10.12
- P/E Ratio
- SPRY N/A
- ECPG N/A
- Revenue Growth
- SPRY 8460.00
- ECPG 7.66
- 52 Week Low
- SPRY $7.55
- ECPG $31.54
- 52 Week High
- SPRY $18.51
- ECPG $51.77
- Technical
- Relative Strength Index (RSI)
- SPRY 55.76
- ECPG 18.21
- Support Level
- SPRY $10.00
- ECPG $32.99
- Resistance Level
- SPRY $11.55
- ECPG $36.78
- Average True Range (ATR)
- SPRY 0.69
- ECPG 2.64
- MACD
- SPRY 0.21
- ECPG -0.96
- Stochastic Oscillator
- SPRY 78.00
- ECPG 2.48
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchase portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumer repay their obligations and work toward financial recovery. Encore has only a reportable segment being portfolio purchasing and recovery.